Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure 4 from Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance
  1. Home
  2. Publications
  3. Supplementary Figure 4 from Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance

Supplementary Figure 4 from Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance

Authors:
  • EJEsther P. Jane
    Esther P. Jane
  • DPDaniel R. Premkumar
    Daniel R. Premkumar
  • STSwetha Thambireddy
    Swetha Thambireddy
  • BGBrian Golbourn
    Brian Golbourn
  • SASameer Agnihotri
    Sameer Agnihotri
  • KBKelsey C. Bertrand
    Kelsey C. Bertrand
  • SMStephen C. Mack
    Stephen C. Mack
  • MMMax I. Myers
    Max I. Myers
  • ACAnsuman Chattopadhyay
    Ansuman Chattopadhyay
  • DTD. Lansing Taylor
    D. Lansing Taylor
  • MSMark E. Schurdak
    Mark E. Schurdak
  • ASAndrew M. Stern
    Andrew M. Stern

Open Access
Publisher website
Google Scholar
  • 3 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1541-7786.22514082
Abstract
No abstract available
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.